Showing results (11-20 of 71) with videos related to

Sort By:
Pageof 8
Current Opinion in Oncology|May 18, 1999
Monoclonal antibodies as potentiators of radiotherapy and chemotherapy in the management of head and neck cancerR H Wheeler, S Spencer, D Buchsbaum, et al.
NCI Monographs : a Publication of the National Cancer Institute|January 1, 1987
Cisplatin and dichloromethotrexate: a pharmacologically rational combinationR B Natale, R H Wheeler, J A Roberts
Investigational New Drugs|January 1, 1985
A phase II trial of aclacinomycin-A in advanced squamous cell carcinoma of the head and neckJ L Eckenrode, R H Wheeler, A A Forastiere
American Journal of Clinical Oncology|October 1, 1994
Phase 2 study of prolonged administration of oral etoposide in combination with weekly cisplatin in advanced non-small cell lung cancerF Robert, R H Wheeler, D Molthrop, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1984
A phase I-II trial of cisplatin and dichloromethotrexate in squamous cell cancer of the head and neckR H Wheeler, R B Natale, S G Roshon, et al.
Investigational New Drugs|January 1, 1983
The cytokinetic and cytotoxic effects of ICRF-159 and ICRF-187 in vitro and ICRF-187 in human bone marrow in vivoR H Wheeler, D J Clauw, R B Natale, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
An in vivo and in vitro trial of aclarubicin in metastatic breast cancer: a novel approach to the study of analogsR B Natale, R L Cody, M S Simon, et al.
Pageof 8